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Extraction and isolation
The dried stems (14.3 kg) of F. formosana f. formosana were exhaustively extracted with cold MeOH and concentrated in vacuo to yield a dark residue (350 g). The MeOH extract was partitioned into an n-hexane-(fr. A, 60 g), a CHCl 3 -(fr. B, 100 g), an n-BuOH-(fr. C, 100 g) and a H 2 O-(fr. D, 90 g) soluble fraction. Fr. B (100 g) was chromatographed over a silica gel (3 kg) column and eluted with a step gradient of CHCl 3 -MeOH (20:1, 10:1, 5:1, 2:1, 1:1, MeOH, 4 l each) to provide 9 frs (B-1 to 9). Fr. B-2 (CHCl 3 -MeOH, 10:1, 254 mg) was re-fractionated over a silica gel (8 g) column eluted with a gradient of CH 2 Cl 2 /EtOAc (CH 2 Cl 2 , 100:1, 50:1, 20:1, 10:1, EtOAc, 60 ml each) to give 9 frs (B 2-1 to 8). Fr. B-2-3 (CH 2 Cl 2 /EtOAc 50:1, 36 mg) was purified with preparative TLC (n-hexane/EtOAc 5:1) to yield 9 (1.7 mg, R f = 0.33, n-hexane/acetone 10:1) and 11 (26 mg, R f = 0.67, n-hexane/EtOAc 5:1). Fr. B-4 (CHCl 3 /MeOH 10:1, 40.8 g) was re-fractionated on silica gel (1.2 kg) and eluted with a gradient of n-hexane/EtOAc (5:1, 3:1, 2:1, 1:1, EtOAc, 1.5 l each) to give 11 frs (B-4-1 to 11).
Fr. B-4-2 (n-hexane/EtOAc 3:1, 136 mg) was subjected to a silica gel (4 g) column and eluted with a gradient of n-hexane/EtOAc (50:1, 20:1, 10:1, 5:1, EtOAc, 25 ml each) to obtain 7 frs (B-4-2-1 to 7). Crystalline frs of B-4-2-4 (n-hexane/EtOAc 20:1, 160 mg) and B-4-2-5 (n-hexane/EtOAc 10:1, 15 mg) were recrystallized from MeOH to obtain 3 (26 mg, R f = 0.30, n-hexane/ EtOH 10:1) and 4 (1 mg, R f = 0.38, n-hexane/acetone 10:1), respectively. Fr. B-4-6 (n-hexane/EtOAc 3:1, 831 mg) was subjected to a Sephadex LH-20 (30 g) column eluted with MeOH (50 ml) to give 7 frs (B-4-6-1 to 7). Crystalline frs of B-4-6-5 (n-hexane/EtOAc 20:1, 71 mg) and B-4-9 (n-hexane/EtOAc 1:1, 4.43 g) were recrystallized from MeOH to yield 5 (2.5 mg, R f = 0.38, n-hexane/acetone 3:1) and 6 (78 mg, R f = 0.50, n-hexane/acetone 1:1), respectively.
The mother liquor (3.68 g) of B-4-9 was subjected to Sephadex LH-20 (120 g) and eluted with MeOH (100 ml) to provide 7 frs (B-4-9-1 to 7). Fr. B-4-9-4 (MeOH, 817 mg) was re-fractionated on silica gel (30 g) eluted with a gradient of CH 2 Cl 2 /MeOH (CH 2 Cl 2 , 100:1, 50:1, 30:1, 10:1, 5:1, MeOH, 50 ml each) to provide 12 frs (B-4-9-4-1 to 12). Fr. B-4-9-4-3 (CH 2 Cl 2 /MeOH 100:1, 35.7 mg) was purified with preparative TLC (n-hexane/EtOAc 3:1) to obtain 10 (14.5 mg, R f = 0.30, n-hexane/EtOAc 3:1). Fr. B-4-9-4-5 (CH 2 Cl 2 /MeOH 50:1, 159 mg) was re-subjected to silica gel (6 g) eluted with a gradient of n-hexane/acetone (2:1, acetone, 25 ml each) to provide 4 frs (B-4-9-4-5-1 to 4). Fr. B-4-9-4-5-2 (n-hexane/acetone 2:1, 37.8 mg) was purified with preparative TLC (CHCl 3 /EtOAc 10:1) to yield 1 (3.2 mg, R f = 0.34, n-hexane/acetone 3:1) and 2 (4.3 mg, R f = 0.36, n-hexane/EtOAc 2:1). Fr. B-6 (CHCl 3 /MeOH 10:3, 2.59 g) was subjected to Sephadex LH-20 (50 g) and eluted with MeOH (200 ml) to provide 11 frs (B-6-1 to 11). Fr. B-6-8 (MeOH, 71 mg) was purified with preparative TLC (CH 2 Cl 2 /acetone 5:1) to give 7 (10 mg, R f = 0.32, CH 2 Cl 2 /acetone 1:1) and 8 (6 mg, R f = 0.38, CH 2 Cl 2 /acetone 2:1). 
Spatheliachromen

Statistical analysis
Data were presented as the mean + SE from three independent experiments. The cytotoxic potency of isolated compounds against human cancer cells was evaluated using the one-way ANOVA and multiple-comparison using Scheffe method. Differences were considered significant when the p-value was < 0.05.
Gibbs test
Gibbs reagent (2,6-dibromoquinonechloroimide) could react with the phenolic compound (the position para to the hydroxy must be un-substituted) to form the blue coloured compound in a buffered solution of pH 9.4 as described by Gibbs. 
